EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, NEO: Neogenomics Inc

24 Oct 25 15:59
LAST:

10.66

CHANGE:
 0.22		OPEN:
10.62		HIGH:
10.70		ASK:
8.25		VOLUME:
2.52M
CHG(%):
2.11		PREV:
10.45		LOW:
10.50		BID:
36.91		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
24 Oct 2510.6210.7010.5010.672.83M
23 Oct 2510.3510.5710.2410.454.39M
22 Oct 2510.3510.5210.1410.343.82M
21 Oct 2510.5710.6510.4310.433.16M
20 Oct 2510.3410.8910.2010.595.73M
17 Oct 2510.0810.3810.0110.053.14M
16 Oct 2510.0010.409.9910.287.49M
15 Oct 259.509.989.509.977.94M
14 Oct 259.259.589.199.384.89M
13 Oct 259.129.629.109.349.45M

COMPANY PROFILE

Name:Neogenomics Inc
About:NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through two segments: Clinical Services and Advanced Diagnostics. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company offers molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.
Sector:Healthcare
Address:9490 NeoGenomics Way, Fort Myers, FL, United States, 33912
Website:https://www.neogenomics.com
CUSIP:64049M209
CIK:0001077183
ISIN:US64049M2098
FIGI:BBG000BKH263

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:10.501.6%
MA10:10.155.0%
MA20:9.4612.7%
MA50:8.3427.8%
MA100:7.5341.6%
MA200:8.9119.6%
STO9:85.43 
STO14:88.57 
RSI14:75.49 
MTM14:1.64
ROC14:0.18 
ATR:0.42 
Week High:10.892.2%
Week Low:10.016.5%
Month High:10.892.2%
Month Low:7.5619.6%
Year High:19.1279.3%
Year Low:4.72125.8%
Volatility:11.56 

RECENT SPLITS

Date Ratio
16 Apr 20031-100
17 Nov 20004-1